{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:11:29Z","timestamp":1792084289988,"version":"4.4.0"},"publisher-location":"Boston, MA","reference-count":55,"publisher":"Springer US","isbn-type":[{"value":"9781468451931","type":"print"},{"value":"9781468451917","type":"electronic"}],"license":[{"start":{"date-parts":[[1986,1,1]],"date-time":"1986-01-01T00:00:00Z","timestamp":504921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1986,1,1]],"date-time":"1986-01-01T00:00:00Z","timestamp":504921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1986]]},"DOI":"10.1007\/978-1-4684-5191-7_13","type":"book-chapter","created":{"date-parts":[[2012,11,25]],"date-time":"2012-11-25T03:52:14Z","timestamp":1353815534000},"page":"197-215","source":"Crossref","is-referenced-by-count":35,"title":["Neurobiology of D1 Dopamine Receptors after Neonatal-6-OHDA Treatment: Relevance to Lesch-Nyhan Disease"],"prefix":"10.1007","author":[{"given":"George R.","family":"Breese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Celeste","family":"Napier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary E.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0024-3205(85)90541-7","volume":"37","author":"J Arnt","year":"1985","unstructured":"Arnt, J., 1985, Hyperactivity induced by stimulation of separate D1 and D2 receptors in rats with bilateral 6-OHDA lesions, Life Sci., 37:717\u2013723.","journal-title":"Life Sci."},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0014-2999(84)90267-X","volume":"102","author":"J Arnt","year":"1984","unstructured":"Arnt, J., and Hyttel, J., 1984, Differential inhibition by dopamine D1 and D2 antagonists of circling behavior induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions, Europ. J. Pharmacol., 102:349\u2013354.","journal-title":"Europ. J. Pharmacol."},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0304-3940(83)90548-7","volume":"35","author":"P Bevan","year":"1983","unstructured":"Bevan, P., 1983, Repeated apomorphine treatment causes behavioral supersensitivity and dopamine D2 receptor hyposensitivity, Neurosci. Letter, 35:185\u2013189.","journal-title":"Neurosci. Letter"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/0024-3205(84)90540-X","volume":"35","author":"W Billard","year":"1984","unstructured":"Billard, W., Ruperto, V., Crosby, G., Iorio, L.C., and Barnett, A., 1984, Characterization of the binding of 3H-SCH 23390, a selective D1 receptor antagonist ligand, in rat striatum, Life Sci., 35:1885\u20131893.","journal-title":"Life Sci."},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3565(25)28637-2","volume":"174","author":"GR Breese","year":"1970","unstructured":"Breese, G.R. and Traylor, T.D. Effects of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons, 1970, J. Pharmacol. Exp. Ther., 174:413\u2013420. .","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"13_CR6","first-page":"44","volume":"210\u2013222","author":"GR Breese","year":"1972","unstructured":"Breese, G.R., and Traylor, T.D., 1972, Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rats: Effects of 6-hydroxydopamine, Brit. J. Pharmacol., 44:210\u2013222.","journal-title":"Brit. J. Pharmacol."},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0091-3057(84)80110-0","volume":"21","author":"GR Breese","year":"1984","unstructured":"Breese, G.R., Baumeister, A.A., McCown, T.J., Emerick, S.G., Frye, G.D. and Mueller, R.A., 1984a, Neonatal-6-hydroxydopamine: Model of susceptibility for self-mutilation in the Lesch-Nyhan Syndrome, Pharmacol. Biochem. Behav., 21:459\u2013461.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-3565(25)21630-5","volume":"231","author":"GR Breese","year":"1984","unstructured":"Breese, G.R., Baumeister, A.A., McCown, T.J., Emerick, S.G., Frye, G.D., Crotty, K., and Mueller, R.A., 1984b, Behavioral differences between neonatal and adult-6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine, J. Pharmacol. Exp. Ther., 231:343\u2013354.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"13_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0022-3565(25)23963-5","volume":"235","author":"GR Breese","year":"1985","unstructured":"Breese, G.R., Baumeister, A., Napier, T.C., Frye, G.D., and Mueller, R.A., 1985a, Evidence that D1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine, J. Pharmacol. Exp. Ther., 235:287\u2013295.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"13_CR10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/B978-0-08-017922-3.50132-5","volume-title":"Frontiers in Catecholamine Research","author":"GR Breese","year":"1973","unstructured":"Breese, G.R., Cooper, B.R. and Smith, R.D., 1973, Biochemical and behavioral alterations following 6-hydroxydopamine administration into brain. In: \u201cFrontiers in Catecholamine Research\u201d, Usdin, E. and Snyder, S. (Eds.). Pergamon Press, pp. 701\u2013706."},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0014-2999(85)90349-8","volume":"113","author":"GR Breese","year":"1985","unstructured":"Breese, G.R. and Mueller, R.A., 1985, SCH 23390 antagonism of a D2 dopamine agonist depends upon catecholaminergic neurons, Europ. J. Pharmacol., 113:109\u2013114.","journal-title":"Europ. J. Pharmacol."},{"key":"13_CR12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0022-3565(25)31651-4","volume":"209","author":"GR Breese","year":"1979","unstructured":"Breese, G.R., Mueller, R.A., and Mailman, R.B., 1979, Effects of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: Relation of guanosine 3\u20195\u2019-monophosphate (cGMP) changes in cerebellum to behavior, J. Pharmacol. Exp. Ther., 209:262\u2013270.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3565(25)23467-X","volume":"234","author":"GR Breese","year":"1985","unstructured":"Breese, G.R., Napier, T.C., and Mueller, R.A., 1985c, Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: Functional supersensitivity of D1 dopamine receptors in neonatally lesioned rats, J. Pharmacol Exp. Ther., 234:447\u2013455.","journal-title":"J. Pharmacol Exp. Ther."},{"key":"13_CR14","first-page":"928","volume":"43","author":"GR Breese","year":"1984","unstructured":"Breese, G.R., McCown, T.J., Baumeister, A.A., Emerick, S.G., Frye, G.D. and Mueller, R.A., 1984c, L-DOPA induced self-biting in rats treated with 6-hydroxydopamine as neonates: Model of self-mutilation observed in Lesch-Nyhan syndrome, Fed. Proc., 43:928.","journal-title":"Fed. Proc."},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/0024-3205(84)90607-6","volume":"34","author":"AV Christensen","year":"1984","unstructured":"Christensen, A.V., Arnt, J., Hyttel, J., Larson, J.J., and Svendsen, O., 1984, Pharmacological effects of a specific dopamine D1 antagonist SCH 23390 in comparison with neuroleptics, Life Sci., 34:1529\u20131540.","journal-title":"Life Sci."},{"key":"13_CR16","first-page":"393","volume":"9","author":"LE Claveria","year":"1975","unstructured":"Claveria, L.E., Teychenne, P.F., Calne, D.B., Petrie, A. and Bassendine, M.F., 1975, Dopaminergic agonists in Parkinsonism, Adv. Neurol., 9:393\u2013397.","journal-title":"Adv. Neurol."},{"key":"13_CR17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-3565(25)29515-5","volume":"185","author":"BR Cooper","year":"1973","unstructured":"Cooper, B.R., Breese, G.R., Grant, L.D., and Howard, J.J., 1973, Effects of 6-hydroxydopamine treatments on active avoidance responding: Evidence for involvement of brain dopamine, J. Pharmacol. Exp. Ther., 185:358\u2013370.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF00518775","volume":"326","author":"B Costall","year":"1984","unstructured":"Costall, B., Kelley, M.E., and Naylor, R.J., 1984, Unilateral striatal denervation: Reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behavior, Nauyn-Schmeideberg\u2019s Arch. Pharmacol., 326:29\u201335.","journal-title":"Nauyn-Schmeideberg\u2019s Arch. Pharmacol."},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-2999(75)90072-2","volume":"31","author":"B Costall","year":"1975","unstructured":"Costall, B., Naylor, R.J., and Neumeyer, J.L., 1975, Differences in the nature of the stereotyped behavior by apomorphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas, Europ. J. Pharmacol., 31:1\u201316.","journal-title":"Europ. J. Pharmacol."},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1126\/science.877576","volume":"197","author":"I Creese","year":"1977","unstructured":"Creese, I., Burt, D.R., and Snyder, S.H., 1977, Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity, Science, 197:596\u2013598.","journal-title":"Science"},{"key":"13_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0140-6736(85)91107-9","volume":"1","author":"M Goldstein","year":"1985","unstructured":"Goldstein, M., Anderson, L.T., Reuben, R. and Dancis, J., 1985, Self-mutilation in Lesch-Nyhan disease is caused by dopaminergic denervation, Lancet, 1:338\u2013339.","journal-title":"Lancet"},{"key":"13_CR22","first-page":"21","volume":"4","author":"M Goldstein","year":"1980","unstructured":"Goldstein, M., Lew, T.Y., Asano, T., and Weta, K., 1980, Alterations in dopamine receptors. Effects of lesions and haloperidol treatment, Comm. Psychopharm., 4:21\u201325.","journal-title":"Comm. Psychopharm."},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0006-8993(81)90614-4","volume":"211","author":"RE Heikkila","year":"1981","unstructured":"Heikkila, R.E., Shapiro, B.S., and Duvoisin, R.C., 1981, The relationship between loss of dopamine nerve terminals, striatal (3H)-spiroperidol binding and rotational behavior in unilaterallly 6-hydroxydopamine-lesioned rats, Brain Res., 211:285\u2013292.","journal-title":"Brain Res."},{"key":"13_CR24","doi-asserted-by":"crossref","unstructured":"Herrera-Marschitz, M., and Ungerstedt, U., Evidence that striatal efferents relate to different dopamine receptors, Brain Res., 323:269\u2013278.","DOI":"10.1016\/0006-8993(84)90297-X"},{"key":"13_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00441377","volume":"36","author":"AS Hollister","year":"1974","unstructured":"Hollister, A.S., Breese, G.R., and Cooper, B.R., 1974, Comparison of tyrosine hydroxylase and dopamine-\u03b2-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity, Psychopharmacologia, 36:1\u201316.","journal-title":"Psychopharmacologia"},{"key":"13_CR26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3565(25)31520-X","volume":"208","author":"AS Hollister","year":"1979","unstructured":"Hollister, A.S., Breese, G.R., and Mueller, R.A., 1979, Role of monoamine neural systems in L-dihydroxyphenylalanine stimulated activity, J. Pharmacol. Exp. Ther., 208:37\u201343.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"13_CR27","first-page":"183","volume":"32","author":"O Hornykiewicz","year":"1973","unstructured":"Hornykiewicz, O., 1973, Parkinson\u2019s disease: From brain homogenate to treatment, Fed. Proc, 32:183\u2013190.","journal-title":"Fed. Proc"},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0364-7722(78)90090-5","volume":"2","author":"J Hyttel","year":"1978","unstructured":"Hyttel, J., 1978, A comparison of the effect of neuroleptic drugs on the binding of 3H-haloperidol and 3H-(Z)-flupentixol and an adenylate cyclase activity in rat striatal tissue in vitro, Prog. Neuro-Psychopharmacol., 2:329\u2013335.","journal-title":"Prog. Neuro-Psychopharmacol."},{"key":"13_CR29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0022-3565(25)21599-3","volume":"226","author":"LC Iorio","year":"1983","unstructured":"Iorio, L.C., Barnett, A., Leitz, F.H., Houser, V.P., and Korduba, A., 1983, SCH-23390, a potential benzazepine antipsychotic with unigue interactions on dopaminergic systems, J. Pharmacol. Exp. Ther., 226:462\u2013468.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"13_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF00429052","volume":"45","author":"DM Jackson","year":"1975","unstructured":"Jackson, D.M., Anden, N-E. and Dahlstrom, A., 1975, A functional effect of dopamine in the nucleus accumbens and in some dopamine-rich areas of the rat brain, Psychopharmacologia, 45:139\u2013149.","journal-title":"Psychopharmacologia"},{"key":"13_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/277093a0","volume":"227","author":"JW Kebabian","year":"1979","unstructured":"Kebabian, J.W., and Calne, D.B., 1979, Multiple receptors for dopamine, Nature (Lond)., 227:93\u201396.","journal-title":"Nature (Lond)."},{"key":"13_CR32","first-page":"1115","volume-title":"Metabolic Basis of Inherited Disease","author":"WN Kelley","year":"1983","unstructured":"Kelley, W.N. and Wyngaarden, T.B., 1983, Clinical syndromes associated with hypoxanthine-guanine-phosphoribosyl-transferase deficiency. In: \u201cMetabolic Basis of Inherited Disease\u201d, edited by Stanberry et al. New York: McGraw Hill, pp. 1115\u20131143."},{"key":"13_CR33","first-page":"562","volume":"5","author":"CD Kilts","year":"1979","unstructured":"Kilts, C.D., Smith, D.A., Ondrusek, M.G., Mailman, R.B., Mueller, R.A., and Breese, G.R., 1979, Differential effects of \u201cDopaminergic agonists\u201d on measures of dopaminergic function, Soc. Neurosci. Abst., 5:562.","journal-title":"Soc. Neurosci. Abst."},{"key":"13_CR34","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJM197206222862503","volume":"286","author":"WL Klawans","year":"1972","unstructured":"Klawans, W.L., Paulson, G.W., Ringel, S.P. and Barbeau A., 1972, Use of L-DOPA in the detection of prof L-DOPA in the detection of presymptomatic Hungtington\u2019s chorea, N. Engl. J. Med., 286:1332\u20131334.","journal-title":"N. Engl. J. Med."},{"key":"13_CR35","first-page":"217","volume":"24","author":"HL Klawans","year":"1979","unstructured":"Klawans, H.L., Hitri, A., Carvey, P.M., Nausieda, P.A. and Weiner, W.J., 1979, Effect of chronic dopaminergic agonism on striatal membrane dopamine binding, Adv. Neurol., 24:217\u2013224.","journal-title":"Adv. Neurol."},{"key":"13_CR36","first-page":"1136","volume":"10","author":"WC Koller","year":"1984","unstructured":"Koller, W.C., Cortin, J.C., and Fields, J.Z., 1984, Pergolide down-regulates D2 dopamine receptors but fails to block haloperidol induced behavioral supersensitivity, Society Neurosci. Abst., 10:1136.","journal-title":"Society Neurosci. Abst."},{"key":"13_CR37","first-page":"22","volume-title":"Dopamine Receptors","author":"PM Laduron","year":"1983","unstructured":"Laduron, P.M., 1983, Commentary: Dopamine-sensitive adenylate cyclase as a receptor site, In: \u201cDopamine Receptors\u201d (ed. C. Kaiser and T.W. Kebabian), Am. Chem. Soc. (Washington, D.C.) pp. 22\u201328."},{"key":"13_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/0002-9343(64)90104-4","volume":"36","author":"M Lesch","year":"1964","unstructured":"Lesch, M. and Nyhan, W.L., 1964, A familial disorder of uric acid metabolism and central nervous system function, Am. J. Med., 36:561\u2013570.","journal-title":"Am. J. Med."},{"key":"13_CR39","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJM198111053051902","volume":"305","author":"KG Lloyd","year":"1981","unstructured":"Lloyd, K.G., Hornykiewicz, O., Davidson, L., Shannak, K., Farley, I., Goldstein, M., Shibuya, M., Kelley, W.N., and Fox, I.H., 1981, Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome, N. Eng. J. Med., 305:1106\u20131111.","journal-title":"N. Eng. J. Med."},{"key":"13_CR40","first-page":"291","volume":"40","author":"RB Mailman","year":"1981","unstructured":"Mailman, R.B., Kilts, C.D., Beaumont, K., and Breese, G.R., 1981, \u201cSupersensitivity\u201d of dopamine systems: Comparisons between haloperidol withdrawal, intracisternal and unilateral 6-hydroxydopamine (6-OHDA) treatments, Fed Proc., 40:291.","journal-title":"Fed Proc."},{"key":"13_CR41","first-page":"932","volume":"9","author":"RB Mailman","year":"1983","unstructured":"Mailman, R.B., Towle, A., Schulz, D.W., Lewis, M.H., Breese, G.R., DeHaven, D.H., and Krigman, M.R., 1983, Neonatal 6-OHDA treatment of rats: Changes in dopamine (DA) receptors, striatal neurochemistry and anatomy, Soc. Neurosci. Abstr., 9:932.","journal-title":"Soc. Neurosci. Abstr."},{"key":"13_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0014-2999(84)90044-X","volume":"101","author":"RB Mailman","year":"1984","unstructured":"Mailman, R.B., Schulz, D.W., Lewis, M.H., Staples, L. Rollema, H. and DeHaven, D.L., 1984, SCH 23390: A selective D1 dopamine antagonist with potent D-2 behavioral actions, Europ. J. Pharmacol., 101:159\u2013160.","journal-title":"Europ. J. Pharmacol."},{"key":"13_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/BF00427697","volume":"82","author":"AG Molloy","year":"1984","unstructured":"Molloy, A.G. and Waddington, T.L., 1984, Dopaminergic behavior stereospecifically promoted by the D1 agonist R- SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390, Psychopharmacology, 82:409\u2013410.","journal-title":"Psychopharmacology"},{"key":"13_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0006-8993(84)91280-0","volume":"302","author":"KA Neve","year":"1984","unstructured":"Neve, K.A., Altar, C.A., Wong, C.A., and Marshall, T.F., 1984, Quantitative analysis of (3H) spiroperidol binding to rat forebrain sections: Plasticity of neostriatal dopamine receptors after nigrostriatal injury, Brain Res., 302:9\u201318.","journal-title":"Brain Res."},{"key":"13_CR45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0026-895X(25)13494-9","volume":"28","author":"P Onali","year":"1985","unstructured":"Onali, P., Olianas, M. and Gessa, G.L., 1985, Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum, Mol. Pharmacol., 28:138\u2013145.","journal-title":"Mol. Pharmacol."},{"key":"13_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0014-2999(76)90299-5","volume":"35","author":"AJJ Pijnenburg","year":"1976","unstructured":"Pijnenburg, A.J.J., Honig, W.M.M., Van Der Heyden, J.A.M., and Van Rossum, J.M., 1976, Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity, Europ. J. Pharmacol., 35:45\u201358.","journal-title":"Europ. J. Pharmacol."},{"key":"13_CR47","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/BF00431451","volume":"84","author":"TE Robinson","year":"1984","unstructured":"Robinson, T.E., 1984, Behavioral sensitization: Characteristics of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats, Psychopharmacology, 84:466\u2013475.","journal-title":"Psychopharmacology"},{"key":"13_CR48","doi-asserted-by":"crossref","unstructured":"Schoenfeld, R., and Uretsky, N., 1972, Altered response to apomorphine in 6-hydroxydopamine-treated rats, Europ. J. Pharmacol., 19:115\u2013118.","DOI":"10.1016\/0014-2999(72)90085-4"},{"key":"13_CR49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0031-6997(25)06839-5","volume":"32","author":"P Seeman","year":"1980","unstructured":"Seeman, P., 1980, Brain dopamine receptors, Pharmacol. Rev., 32:229\u2013313.","journal-title":"Pharmacol. Rev."},{"key":"13_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0014-2999(78)90148-6","volume":"50","author":"PE Setler","year":"1978","unstructured":"Setler, P.E., Sarau, H.M., Zirkle, CL., and Saunders, H.L., 1978, The central effects of a novel dopamine agonist, Europ. J. Pharmacol., 50:419\u2013430.","journal-title":"Europ. J. Pharmacol."},{"key":"13_CR51","first-page":"185","volume":"609\u2013619","author":"RD Smith","year":"1973","unstructured":"Smith, R.D., Cooper, B.R., and Breese, G.R., 1973, Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: Evidence for involvement of brain dopamine, J. Pharmacol. Exp. Ther., 185:609\u2013619.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"13_CR52","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0006-8993(81)90704-6","volume":"211","author":"DA Staunton","year":"1981","unstructured":"Staunton, D.A., Wolfe, B.B., Groves, P.M., and Molinoff, P.B., 1981, Dopamine receptor changes following destruction of the nigrostriatal pathway: Lack of a relationship to rotation behavior, Brain Res., 211:315\u2013327.","journal-title":"Brain Res."},{"key":"13_CR53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/292463a0","volume":"292","author":"K Tsuruta","year":"1981","unstructured":"Tsuruta, K., Frey, E.A., Grewe, C.W., Cote, T.E., Eskay, R.L., and Kebabian, T.W., 1981, Evidence that LY-141865 specifically stimulates the D2 dopamine receptor, Nature (Lond), 292:463\u2013465.","journal-title":"Nature (Lond)"},{"key":"13_CR54","first-page":"69","volume":"367","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt, U., 1971, Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system, Acta Physiol. Scand., Supplement367, pp. 69\u201393.","journal-title":"Scand., Supplement"},{"key":"13_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/301069a0","volume":"301","author":"SI Walaas","year":"1983","unstructured":"Walaas, S.I., Aswad, D.W., and Greengard, P., 1983, A dopamine and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions, Nature, 301:69\u201371.","journal-title":"Nature"}],"container-title":["Advances in Experimental Medicine and Biology","Neurobiology of Central D1-Dopamine Receptors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4684-5191-7_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T17:46:47Z","timestamp":1745344007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4684-5191-7_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986]]},"ISBN":["9781468451931","9781468451917"],"references-count":55,"URL":"https:\/\/doi.org\/10.1007\/978-1-4684-5191-7_13","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[1986]]}}}